1. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002
2. Introduction of combined CHOP-rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma (DLBC) in British Columbia (BC);Sehn;Blood,2003
3. Randomized intergroup trial of firstline treatment for patients >=60 years with diffuse large B-cell non- Hodgkin's lymphoma (DLBCL) with a CHOP-like regimen with or without the anti-CD20 antibody rituximab-early stopping after the first interim analysis;Pfreundschuh;Proc Am Soc Clin Oncol,2004
4. Rituximab-CHOP versus CHOP with or without maintenance rituximab in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL);Habermann;Blood,2004
5. Doseadjusted EPOCH-rituximab is highly effective in the GCB and ABC subtypes of untreated diffuse large Bcell lymphoma;Wilson;Blood,2004